Scientific Advisors

Douglas Hay, PhD

Scientific Advisor

President, Hay Drug Discovery Consulting, LLC

Former VP of COPD Drug Discovery, GSK

Phil Haywood, PhD

Inhalation Formulation Advisor

Inhalation Product Development Consultant, Haywood Consulting

Former Head of Inhalation Development, Novartis and GlaxoWellcome

Jeffrey Edelson, MD FRCPC MHSc

Clinical Development Advisor

Chief Medical Officer, Palatin Technologies

Principal, Aequanimitas Consulting

Extramural entrepreneur, Bioadvance

Adjunct Associate Professor of Medicine, University of Pennsylvania Lung Center

Tim McGovern, PhD

Inhalation Toxicology Advisor

Toxicology/Regulatory Consultant, Scilucent

Former Supervisory Pharmacologist, FDA, Division of Pulmonary and Allergy Products